Jerusalem-based equity crowdfunding platform OurCrowd announced this week that a consortium it established in partnership with Perrigo, a private label over-the-counter pharmaceuticals manufacturer and BoL Pharma, one of the first licensed cannabis cultivators in Israel, has won a tender by the Israel Innovation Authority to operate the government-backed incubator, dubbed CanNegev. Read...
Read MoreOurCrowd, the leading global investment platform and the most active venture capital investor in Israel, Perrigo, the world’s largest non-prescription drug company, and BOL Pharma, the leading medical cannabis company in Israel and an OurCrowd portfolio company, today announced that the consortium they established won the tender issued by the Israel Innovation Authority to operate CanNegev, a medical cannabis incubator which will be located in Yeruham in the south of Israel. Read...
Read More-OurCrowd, the leading global investment platform and the most active venture capital investor in Israel, Perrigo, the world’s largest non-prescription drug company, and BOL Pharma, the leading medical cannabis company in Israel and an OurCrowd portfolio company, today announced that the consortium they established won the tender issued by the Israel Innovation Authority to operate CanNegev, a medical cannabis incubator which will be located in Yeruham in the south of Israel. Read...
Read MoreProjecting an estimated investment of NIS 150 million into the small Negev town, the tender to operate the government-backed CanNegev incubator was awarded to crowdfunding investment platform OurCrowd, nonprescription pharmaceutical giant Perrigo and Israeli medical cannabis cultivator BOL Pharma. Read...
Read More
It’s been an active week for us as we begin the global expansion of our incubator business…..with our first international win, in New Zealand – hotbed of agtech/foodtech together with our partners Sprout, Finistere, Fonterra, and Gallagher…. In an exciting exit, Intel acquires Habana Labs for $2B. This news is obviously very positive for other companies in the AI accelerator chip business. Hailo, an OurCrowd portfolio company in which we are currently re-investing, is in this space with its edge devices which — according to Hailo — can now run deep learning applications at full scale more efficiently, effectively, and sustainably than traditional solutions, while significantly lowering costs. Great news from the SEC, proposing to make private investments (like OurCrowd) more accessible to the broader community. Kudos to Chairman Clayton and team….Read more on TechCrunch. Startup Nation and beyond Congrats to Arbe on its $32 million raise which OurCrowd was happy to take part in: Arbe raises $32 million to bring its high-resolution radar to autonomous vehicles. Huge news: Israel’s Zebra Medical Vision has teamed up with Johnson &...
Read More
